Commercial excellence is a journey. It calls for continuous self-assessment and improvement, as well as the agile adoption of new global best practices to find areas where significant growth is possible.
Orion’s Commercial Excellence team helps business-to-business partners in building brands and commercializing products in different market areas.
We have extensive experience in commercializing inhaled pharmaceuticals that meet the needs of patients with asthma or COPD today and in the future. Our commercial expertise spans from brand building to launching new products and all the way to meeting the demands of health care professionals and patients. Digital applications to enhance the well-being of patients with respiratory illnesses are also in our focus.
We offer you:
Global brand building knowhow:
As our partner you can expect full support from our global brand team to provide you with an extensive branding and training package allowing you to build a strong brand and consistent customers experience in your market.
Commercialisation expertise:
We know how to bring a product to market, create demand and maximise its value. Successful commercialisation not only depends on our own actions—we can help you to assure that the timing and market situation are right for your business as well.
Orion is constantly seeking and evaluating potential new partnerships including those with companies outside Europe, such as in the Asia-Pacific region. The main focus indications are asthma and chronic obstructive pulmonary disease (COPD), but we are also interested in other indications such as allergies.
If your company is interested in finding a partner in commercialising respiratory pharmaceuticals, bringing your products to market, or using Orion’s proprietary dry powder inhaler (DPI) technology platform, contact us by filling in the form below.
